Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label in an attempt to suppress behavioral estrus. However, a controlled research study found that MPA was not effective at suppression of behavioral estrus.1 Many veterinarians believe MPA modifies behavior by producing a calming effect in the horse and does not have a therapeutic benefit that goes beyond this behavior modification. Therefore, the AAEP recommends that MPA should not be administered to horses in competition.
1. Gee EK, C DeLuca, JL Stylski, PM McCue. Efficacy of medroxyprogesterone acetate in suppression of estrus in cycling mares. J Equine Vet Sci 2009;29:140-145.
Currently under review.
Related Resources
Position on the Use of Therapeutic Medication in the Racehorse
The AAEP policy on medication in pari-mutuel racing is driven by our…
Position on the Judicious Use of Antimicrobials
Antimicrobial agents are necessary to manage infectious diseases in horses, but adverse…
Position on the Use of Vesicants
The AAEP does not support the use of vesicants and internal blistering…